A

F

AMORUSO , Fabrizio

Last name: AMORUSO

First name: Fabrizio

2022 (v1)

Publication

Metadata-only

Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)

Malagoli, Piergiorgio Dapavo, Paolo Pavia, Giulia

Psoriasis is one of the commonest inflammatory skin diseases determining a very high impact on patients' quality of life and daily activities and relationships. Several biologic therapies have been approved through the years for the treatment of moderate-to-severe plaque psoriasis, and efficacy and safety profile have been analyzed in clinical...

Uploaded on: February 4, 2024